Roex G - Search Results

1

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.

Roex G, Timmers M, Wouters K, Campillo-Davo D, Flumens D, Schroyens W, Chu Y, Berneman ZN, Lion E, Luo F, Anguille S. Roex G, et al. J Hematol Oncol. 2020 Dec 3;13(1):164. doi: 10.1186/s13045-020-01001-1. J Hematol Oncol. 2020. PMID: 33272302 Free PMC article.

2

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Roex G, Campillo-Davo D, Flumens D, Shaw PAG, Krekelbergh L, De Reu H, Berneman ZN, Lion E, Anguille S. Roex G, et al. J Transl Med. 2022 Mar 14;20(1):124. doi: 10.1186/s12967-022-03326-6. J Transl Med. 2022. PMID: 35287669 Free PMC article.

3

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.

Timmers M, Roex G, Wang Y, Campillo-Davo D, Van Tendeloo VFI, Chu Y, Berneman ZN, Luo F, Van Acker HH, Anguille S. Timmers M, et al. Among authors: roex g. Front Immunol. 2019 Jul 16;10:1613. doi: 10.3389/fimmu.2019.01613. eCollection 2019. Front Immunol. 2019. PMID: 31379824 Free PMC article. Review.

4

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

Campillo-Davo D, De Laere M, Roex G, Versteven M, Flumens D, Berneman ZN, Van Tendeloo VFI, Anguille S, Lion E. Campillo-Davo D, et al. Among authors: roex g. Pharmaceutics. 2021 Mar 16;13(3):396. doi: 10.3390/pharmaceutics13030396. Pharmaceutics. 2021. PMID: 33809779 Free PMC article. Review.

5

Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.

Wang Y, Gao Y, Niu C, Wang B, Zhao S, Roex G, Qian J, Qie J, Chen L, Yi C, Anguille S, Liu J, Luo F, Chu Y. Wang Y, et al. Among authors: roex g. Cancer Immunol Immunother. 2022 Nov;71(11):2801-2814. doi: 10.1007/s00262-022-03195-4. Epub 2022 Apr 19. Cancer Immunol Immunother. 2022. PMID: 35441325 Free PMC article.

6

The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.

Van Acker HH, Campillo-Davo D, Roex G, Versteven M, Smits EL, Van Tendeloo VF. Van Acker HH, et al. Among authors: roex g. Cytokine Growth Factor Rev. 2018 Jun;41:54-64. doi: 10.1016/j.cytogfr.2018.05.002. Epub 2018 May 16. Cytokine Growth Factor Rev. 2018. PMID: 29773448 Review.

7

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.

Van Acker HH, Versteven M, Lichtenegger FS, Roex G, Campillo-Davo D, Lion E, Subklewe M, Van Tendeloo VF, Berneman ZN, Anguille S. Van Acker HH, et al. Among authors: roex g. J Clin Med. 2019 Apr 27;8(5):579. doi: 10.3390/jcm8050579. J Clin Med. 2019. PMID: 31035598 Free PMC article. Review.

8

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data.

Roex G, Feys T, Beguin Y, Kerre T, Poiré X, Lewalle P, Vandenberghe P, Bron D, Anguille S. Roex G, et al. Pharmaceutics. 2020 Feb 24;12(2):194. doi: 10.3390/pharmaceutics12020194. Pharmaceutics. 2020. PMID: 32102267 Free PMC article. Review.

9

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.

Campillo-Davo D, Versteven M, Roex G, Reu H, Heijden SV, Anguille S, Berneman ZN, Tendeloo VFIV, Lion E. Campillo-Davo D, et al. Among authors: roex g. Cancers (Basel). 2020 Jan 21;12(2):256. doi: 10.3390/cancers12020256. Cancers (Basel). 2020. PMID: 31972992 Free PMC article.

10

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

Van den Eynde A, Gehrcken L, Verhezen T, Lau HW, Hermans C, Lambrechts H, Flieswasser T, Quatannens D, Roex G, Zwaenepoel K, Marcq E, Joye P, Cardenas De La Hoz E, Deben C, Gasparini A, Montay-Gruel P, Le Compte M, Lion E, Lardon F, Van Laere S, Siozopoulou V, Campillo-Davo D, De Waele J, Pauwels P, Jacobs J, Smits E, Van Audenaerde JRM. Van den Eynde A, et al. Among authors: roex g. J Hematol Oncol. 2024 Feb 9;17(1):8. doi: 10.1186/s13045-024-01525-w. J Hematol Oncol. 2024. PMID: 38331849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page